TPG buys up Asian pathology unit of Australian private equity target Healthscope

TPG Capital has agreed an A$279m buyout of Australian private healthcare business Healthscope's Asian pathology operations, just months after the company rejected a pair of $3bn-plus PE takeover offers for its overall business.